Edesa Biotech Inc. (NASDAQ: EDSA) Stock Information | RedChip

Edesa Biotech Inc. (NASDAQ: EDSA) Listen to this Section


$4.41
+0.0900 ( +2.08% ) 2.6K

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Market Data


Open


$4.41

Previous close


$4.32

Volume


2.6K

Market cap


$14.22M

Day range


$4.30 - $6.27

52 week range


$2.46 - $8.33

Insider Ownership Transactions

Total Amount Purchased: -39,504.00 | $ -174,212.64

Date Type Amount Purchased Purchaser
2024-08-02 Sale -3317.00 Nijhawan Pardeep
2024-07-03 Sale -4015.00 Nijhawan Pardeep
2024-06-04 Sale -4785.00 Nijhawan Pardeep
2024-05-01 Sale -3083.00 Nijhawan Pardeep
2024-04-02 Sale -3253.00 Nijhawan Pardeep
2024-03-25 Buy 5000.00 Nijhawan Pardeep
2024-03-01 Sale -2765.00 Nijhawan Pardeep
2024-02-02 Sale -2978.00 Nijhawan Pardeep
2024-01-12 Sale -2908.00 Nijhawan Pardeep
2023-08-04 Sale -17400.00 Lemieux Stephen

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 09, 2024
10-q Quarterly Reports 61 Aug 09, 2024
4 Insider transactions 1 Aug 02, 2024
4 Insider transactions 1 Jul 03, 2024
8-k 8K-related 17 Jun 24, 2024
4 Insider transactions 1 Jun 04, 2024
8-k 8K-related 16 May 30, 2024
8-k 8K-related 17 May 10, 2024
10-q Quarterly Reports 62 May 10, 2024
4 Insider transactions 1 May 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.